Idea backed by more than 60 countries, including the United States
TUESDAY, June 8, 2021 (HealthDay News) — A proposal to ease patents and related protections on COVID-19 vaccines in order to help developing nations fight the pandemic will be considered at a two-day meeting of a World Trade Organization (WTO) panel.
The idea is backed by more than 60 countries, including the United States, but faces opposition from other wealthy nations with strong pharmaceutical sectors, the Associated Press reported.
At the meeting that begins Tuesday, the WTO panel will consider a revised proposal from India and South Africa for a temporary international property waiver on COVID-19 vaccines.
The European Union tabled an alternative proposal that relies on existing WTO rules that allow governments to grant production licenses to manufacturers in their countries without the consent of the patent holders in times of emergency, the AP reported.
Nearly 3 in 4 Older Adults Express Interest in Vaccine to Prevent Dementia 
Updated COVID-19 Shot Beneficial for Those With Autoimmune Rheumatic Disease 
AAP Issues Recommendations for Pediatric RSV Vaccination in 2026-2027 Season 
Trends Reported in Vaccination Coverage for Adolescents for 2025 .jpg)
Considerable Gaps Reported in Care for Youth With Opioid Use Disorder 
Nutritional Deficiencies Seen in Youth Taking GLP-1 Receptor Agonists 
Youth Suicide Risk Linked to Community Firearm Violence 
Social Media Warnings Could Discourage Use Among Teens, Young Adults 
.jpg)
